Results 1 to 10 of about 905,195 (217)
Definition of clinical immunology around the globe [PDF]
Immunology has gradually become a core part of many medical specialties. Immune cells and immune mediators are now known to participate in the pathogenesis of a wide variety of diseases and therapies based on the modulation of immune function are ...
José C. Crispín +14 more
doaj +2 more sources
Clinical immunology in chromatinopathies: a scoping review [PDF]
BackgroundChromatinopathies (CP) are a subclass of monogenic neurodevelopmental disorders caused by germline mutations in genes involved in epigenetic regulation.
Dieke Jans +8 more
doaj +2 more sources
Supporting Careers of Women in Clinical Immunology: From Conceptualization to Implementation. [PDF]
Dimitriades VR +3 more
europepmc +2 more sources
Clinical immunology is a medical specialty with a pathogenetic rather than organ-based focus. The main clinical areas covered are allergic disease, autoimmune disease, lymphoproliferative disease, transplantation and immunodeficiency. The role and training of the physician immunologist and the organ-based specialist with an interest are outlined.
J. Brostoff +3 more
+7 more sources
Intensive Infection Control at a Canadian Tertiary Allergy and Clinical Immunology Clinic during COVID-19 to Provide Crucial Services [PDF]
Valois J +4 more
europepmc +3 more sources
BackgroundCurrent standard-of-care treatments for hypereosinophilic syndrome (HES) include oral corticosteroids (OCS) and immunosuppressive/cytotoxic (IS/CT) therapies.
Andreas Reiter +6 more
doaj +1 more source
Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea [PDF]
Background/Aims Despite the clinical importance anaphylaxis and the recent increase in its occurrence, studies regarding the epidemiology of anaphylaxis, risk factors for anaphylaxis, and epinephrine auto-injector (EAI) prescription status for patients ...
Hyunseok Cho, Jae-Woo Kwon
doaj +1 more source
Tumor mutation burden (TMB) is a widely recognized biomarker for predicting the efficacy of immunotherapy. However, its use still remains highly controversial.
Yuqian Liu +16 more
doaj +1 more source
Tumor mutation burden (TMB) is a recognized stratification biomarker for immunotherapy. Nevertheless, the general TMB-high threshold is unstandardized due to severe clinical controversies, with the underlying cause being inconsistency between multiple ...
Yixuan Wang +12 more
doaj +1 more source

